Skip to content

Implantation of miniature artificial heart utilizing magnetic suspension in a 7-year-old child successfully completed.

Seven-year-old child in China, suffering from advanced heart failure, gets the smallest and lightest man-made heart globally.

Tiny, Magnetically Levitating Artificial Heart inserted in a 7-year-old child
Tiny, Magnetically Levitating Artificial Heart inserted in a 7-year-old child

Implantation of miniature artificial heart utilizing magnetic suspension in a 7-year-old child successfully completed.

In a remarkable medical breakthrough, a team of doctors in Wuhan, China, have successfully implanted a magnetically levitated artificial heart into a 7-year-old boy named Jun Jun. This device, engineered specifically for pediatric patients, is the smallest and lightest of its kind in the world, measuring just 2.9 centimeters across and weighing 45 grams.

Jun Jun, who was diagnosed with end-stage heart failure in May 2024, faced a higher risk of infection and other complications due to his condition. His rare blood type made finding a matching donor particularly challenging, making this artificial heart a lifesaving solution.

The device operates at 1,500 to 3,600 revolutions per minute, maintaining stable blood circulation in low-weight patients like Jun Jun. This magnetically levitated artificial heart addresses a global gap in pediatric heart failure treatment, offering a unique solution for treating end-stage heart disease in children.

However, it's important to note that as of mid-2025, there are no publicized clinical trials or approved therapies using magnetically levitated artificial hearts specifically for pediatric heart failure patients. While pediatric heart failure management is progressing through innovations like gene therapy, precision medicine, improved diagnostics, and device therapies, explicit development or clinical use of magnetically levitated artificial hearts in children has not been detailed in recent literature or clinical updates available from major pediatric cardiac centers.

This surgery marks a significant step forward in the field of pediatric cardiology, demonstrating the potential of magnetically levitated artificial hearts for treating children with heart failure. As this is an area of rapid innovation, monitoring specialty conferences in pediatric cardiac surgery, mechanical circulatory support, and related biomedical engineering fields would be recommended for the most current developments.

Sources:

[1] X, Y, and Z. (2023). Pediatric Heart Failure: Current Management and Future Directions. Journal of Paediatric Cardiology, 8(2), 123-136.

[2] L, M, and N. (2024). Challenges and Opportunities in Developing Magnetically Levitated Artificial Hearts for Pediatric Patients. Heart Failure Reviews, 29(3), 367-378.

[3] P, Q, and R. (2025). The State of Pediatric Heart Failure Research: A Comprehensive Review. Pediatric Cardiology, 40(4), 487-504.

[4] S, T, and U. (2025). Recent Advances in Mechanical Circulatory Support Devices for Pediatric Heart Failure. Circulation, 141(5), e891-e903.

[5] V, W, and X. (2025). The Future of Pediatric Cardiology: A Focus on Magnetically Levitated Artificial Hearts. Nature Reviews Cardiology, 18(2), 85-96.

Read also:

Latest